27 February 2018 in Trials
Most patients who undergo abdominal surgery recover bowel movements within a week; however, some suffer prolonged intestinal paralysis or postoperative ileus (POI) leading to complications, such as infection and intestinal adhesions, which can extend hospitalization and increase readmission rates, and consequently increasing healthcare costs. Chinese medicine is effective for accelerating the recovery of gastrointestinal function after abdominal surgery. Xiangbin prescription (XBP) is the standard prescription for this purpose in our hospital; however, randomized controlled trials of it have not yet been conducted. This double-blind, randomized controlled clinical trial aims to recruit patients who have undergone abdominal surgery and experienced postoperative dysmotility to evaluate the efficacy and safety of XBP for preventing POI and accelerating recovery. The research will tackle the common problem of slow recovery of gastrointestinal function after surgery. The participants will be patients who undergo laparoscopic radical resection of rectal carcinoma or laparoscopic panhysterectomy of a benign lesion. Primary outcome measures will be time to first flatus, defecation, normal bowel sounds, and liquid/semi-liquid/general diet. Good Clinical Practice (GCP) standards of efficacy and safety will also be evaluated, along with objective investigation of the mechanism of action of ghrelin. This pivotal trial will be a standardized, scientific, clinical trial designed to evaluate the use of XBP for the recovery of gastrointestinal function after surgery, and it will conform to international standards for clinical trials for the recognition of traditional Chinese medicine. Chinese Clinical Trial Registry, ID: ChiCTR-TRC-14004156 . Registered on 3 January 2014.
30 December 2019 in Research Square
Background and purpose Abdominal surgery is the main department of gynaecology operation. Accelerating the recovery of gastrointestinal function after surgery can not only make patients early recovery diet, but also can reduce the common complications such as pelvic adhesion. It’s important to the rehabilitation and prognosis of patients. The Chinese medicine has been proven to accelerate the recovery of bowel function after the gynecologic abdominal surgery. Most of the indicators used to evaluate gastrointestinal motility recovery are scattered, and there is no standardized evaluation criterion so far. We found that there is not a scale for evaluating the gastrointestinal motility in perioperative period after reviewing a large number of literatures. The Postoperative Clinical Evaluation Criteria for Gastrointestinal Motility (PCECGM) became the local standard of Guangdong province (DB44/t 1581-2015) issued by the quality supervision bureau of Guangdong province in 2015, and a clinical evaluation now is necessary. Study design Cohort study (Diagnostic); Level of evidence, 2. Methods This prospective study was performed in the department of gynecology department at the Guangdong Province Traditional Medical Hospital from Mar. 2015 and Jun. 2017. Patients who diagnosed with benign lesion after laparoscopic total hysterectomy were included in this study. The purpose of this research was to evaluate reliability, validity and responsiveness of the PCECGM. Results 202 patients were included in this study, and the response , completion rate, complete time of the scale were 100%, 99.01% and(95.49士16.69)min, showing the good acceptability. The Cronbach’s Alpha coefficient and spearman-brown were 0.62 and 0.71 respectively. KMO is 0.58, and Bartlett's Test of Sphericity is 181.01, P<0.001. Two factors were extracted according to the factor analysis, and the cumulative contribution rate is 56.33%. The total score of the patients after treatment was significantly higher, P<0.001, and standardized effect value and standardized reaction mean were all 1.32, indicating a high degree of reactivity. Conclusions The properties of “Postoperative clinical evaluation criteria for gastrointestinal motility” are acceptable. It is an effective tool for the evaluation of gastrointestinal motility after the gynecologic abdominal surgery. Introduction Perioperative gastrointestinal dysfunction refers to the perioperative gastrointestinal function of all aspects such as sports secretion defense digestion absorption excretion disorders or weakened. Gastrointestinal motility disorder is the main cause of postoperative gastrointestinal dysfunction. At present, there is no uniform standard for postoperative gastrointestinal motility evaluation in clinical practice. It’s important to the rehabilitation and prognosis of patients. The Postoperative Clinical Evaluation Criteria for Gastrointestinal Motility (PCECGM) became the local standard of Guangdong province (DB44/t 1581-2015) issued by the quality supervision bureau of Guangdong province in 2015.